Navigation Links
Celerion Implements Biometric Fingerprint Technology and Marks Five-Year Anniversary with Verified Clinical Trials
Date:3/13/2017

Celerion was the first early stage contract research organization (CRO) to partner with Verified Clinical Trials to improve participant safety and clinical trial data. Over the last 5 years Celerion performed nearly fifty thousand verifications utilizing the VCT global clinical database registry to identify participants that are currently enrolled in other clinical studies.

Most recently Celerion implemented VCT’s biometric fingerprint technology to augment the accuracy and speed of the verifications performed at our facilities. The use of biometrics adds another layer of protection to ensure dual enrollment in clinical trials does not occur.

Our focus has always been to help our clients get their drugs to market and protect the safety and well-being of our participants. The Verified Clinical Trials database registry enhances our ability to achieve both of those objectives, said Phil Bach, Vice President, Global Clinical Research, Celerion. “Celerion and Verified Clinical Trials share the same vision of applying scientific expertise and advanced technology to ensure the safety of our participants and maintain data integrity leading to successful clinical trial outcomes.”

“Following Celerion’s lead, the majority of Phase I units across North America now utilize the VCT system everyday to protect their clinical trials. Verified Clinical Trials offers the most comprehensive and unique clinical research subject database registry to enhance the quality of both early and late stage studies globally. The system provides a level of safety to the clinical trial process that could not be attained without a solution like Verified Clinical Trials,” said Mitchell Efros, MD FACS, CEO at Verified Clinical Trials.

“By joining forces five years ago, Celerion and VCT led the way in providing a solution that maximizes detection of attempted duplicate enrollment and protocol violations. This combined effort raised awareness and utilization across all phases of clinical research highlighting the need for a research subject database in the clinical trials industry. Working with Celerion’s team over the past five years has been a pleasure” added Kerri Weingard, COO at Verified Clinical Trials.

About Celerion
Translating science into medicine, Celerion is a premier provider of early clinical research and translational clinical pharmacology sciences from their global locations in North America, Europe and Asia.

Celerion conducts First-in-Human, clinical Proof-of-Concept and patient dose response studies, cardiovascular safety and clinical pharmacology research supporting product labeling. With purpose-built clinic and laboratory facilities and highly automated technology, Celerion provides full study services including clinical study conduct, data management and biometrics, PK/PD analysis, bioanalytical services, medical writing, and regulatory and drug development program management. For more information please visit Celerion.

About Verified Clinical Trials
Verified Clinical Trials is a forward thinking company developed by experts active in the clinical research community to proactively improve research subject safety and data quality in clinical research trials. Verified Clinical Trials defines itself as the world’s leader in the field of database registries in clinical trial research. Verified Clinical Trials is the only clinical research database registry designed specifically to enhance the quality of both early and late phase trials and has the scalability to reach all sites nationally as well as on a global level. Verified Clinical Trials offers numerous other value added services to the clinical research site, CRO, and Pharmaceutical Sponsor, that prove invaluable with regards to financial and legal issues and liabilities. For more information, visit http://www.verifiedclinicaltrials.com.

Read the full story at http://www.prweb.com/releases/CelerionVCT/duplicateenrollment/prweb14142364.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Infinata Implements “Clear Quality” Initiative to Optimize Reliability and Usability of Data, Reports and Analysis for Biopharma and Wealth Management Solutions
2. Sarah Cannon Research Institute Implements Virtify CTRR
3. Life Science Equipment Manufacturer and Distributor Implements Accounts Receivable Collections Software for Sage 100 ERP
4. Kymab Implements Genedata Biologics for High-throughput Antibody Discovery
5. Lajollacooks4u Implements Popular New Team Building Format
6. Sigma Blood Systems Implements PERFEQTA Software With Central Jersey Blood Center
7. Jupiter Medical Center Implements Revolutionary Watson for Oncology to Help Oncologists Make Data-Driven Cancer Treatment Decisions
8. Barska Biometric Fingerprint Scanning Safes Now Available At B&H Photo Video
9. Global Biometric Systems Market Forecast Report - Opportunities to 2018
10. Cartes 2013: DERMALOG Presents World Firsts in Biometrics
11. Biometrics market in South East Asia and ANZ to grow at a CAGR of 15.82 percent over the period 2013-2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2020)... ... August 29, 2020 , ... ... Nutrition manufacturing capability in Wuxi, China. The new plant operation will provide the ... and advanced technology. , “This facility will improve the flexibility of our ...
(Date:8/15/2020)... , ... August 13, 2020 , ... ... annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private ... the American economy’s most dynamic segment—its independent small businesses. Intuit, Zappos, Under Armour, ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... validation engineering firm, is making available for free its new white paper ... concurrent transport simulation testing into today’s biologics licensing application (BLA). In response, ...
(Date:8/7/2020)... ... August 06, 2020 , ... ... industries, announces it has closed on the purchase of greenfield for a new, ... TX and includes over 21 acres in the initial acquisition, with an option ...
Breaking Biology Technology:
(Date:8/21/2020)... ... 20, 2020 , ... NDA Partners Chairman Carl Peck, ... with expertise in clinical trial planning and feasibility, regulatory inspection readiness, and clinical ... his career, Mr. Movahhed has helped design and manage oncology, neurology, cardiovascular, and ...
(Date:8/7/2020)... ... 06, 2020 , ... Alucio™, a fast-growing provider of cloud-based ... and Jessica Wong have joined the company’s leadership team as Vice President of ... heads development efforts for Alucio’s flagship product, Beacon, an innovative cloud-based content management ...
(Date:8/3/2020)... PHOENIX (PRWEB) , ... August 03, 2020 , ... ... the company announced a new partnership with medical equipment manufacturer, Spectrum Solutions, to ... its clients to strengthen their laboratory supply chain for more than 10 years. ...
Breaking Biology News(10 mins):